bacterial pneumonias, which occur less frequently, carry a much higher risk of complications and death (2) .
Streptococcus pneumoniae (pneumococcus) and Haemophilus influenzae are the two bacterial pathogens most commonly isolated in pediatric pneumonia (3) . Since these microorganisms can colonize the upper respiratory tract, aspiration of secretions may lead to pneumonia, especially if an individual's susceptibility to a bacterial infection were increased by malnutrition, viral infection, or other factors that would change the immune response (4) . Colonization of the upper airways by S. pneumoniae can occur during the first few days of life; early colonization is associated with living in a large family and a higher risk of suffering from the disease (5) .
An etiologic diagnosis of pneumococcal pneumonia is often difficult to establish. S. pneumoniae is not easily cultured from blood samples, and invasive diagnostic procedures, such as lung puncture, pose too great a risk for most patients. To cover the possibility of undiagnosed pneumococcal pneumonia, World Health Organiza- of antimicrobial agents such as procaine penicillin, ampicillin, and cotrimoxazole (trimethoprim + sulfamethoxazole) (6, 7) . Worldwide, S. pneumoniae has demonstrated increasing resistance to a variety of antibiotics. Studies in Spain and Hungary have documented resistance to penicillin in 44% and 57% of pneumococcal isolates, respectively. The organism is also frequently resistant to co-trimoxazole and chloramphenicol (8, 9) . The patient's age, the serotypes involved, the time of colonization, rapid recolonization following treatment, prior use of antibiotics, and previous hospitalization are factors that have been found to be associated with the presence of resistant isolates (8) .
In studies in Pakistan, S. pneumoniae serotypes found in the respiratory tract of sick children matched the serotypes in cultures of their blood, and the antibiotic sensitivities of the isolates corresponded in 98% of cases (10) . Thus, in children with pneumonia, the antimicrobial resistance patterns of the S. pneumoniae that cause the invasive disease may be reflected in the nasopharyngeal isolates, a circumstance that would prove useful in implementing epidemiologic surveillance programs in an area. Knowledge of resistance patterns would also allow for better therapeutic case management (11) .
The objectives of the present study were (a) to investigate the frequency of nasopharyngeal colonization by S. pneumoniae in children hospitalized with a diagnosis of pneumonia, (b) to determine these isolates' patterns of resistance to the antibiotics recommended for use in the ARI program, (c) to identify the serotypes of the penicillin-resistant isolates, and (d) to document factors associated with the resistance pattern. Analysis of these data would give an indication of the utility of nasopharyngeal isolates in a surveillance program. Specimen, isolation, and identification. A specimen of nasopharyngeal secretion was obtained from each patient using a flexible Dacron swab and seeded directly onto a trypticase soy agar supplemented with 5% sheep's blood and 5 g/mL gentamicin (12) . Specimens were incubated at 37 o C for 20 to 24 hours in an atmosphere containing 2% to 5% CO 2 (candle jar method). S. pneumoniae identification was based on macroscopic and ␣-hemolytic colony characteristics, microscopic morphology by Gram's stain, optochin sensitivity, and bile solubility (13) .
MATERIALS AND METHODS

Patients
Antimicrobial sensitivity. Susceptibility to penicillin was determined using the Kirby-Bauer disk diffusion method, employing a Mueller-Hinton agar containing 5% sheep's blood and 1 g oxacillin disks (screening test). This same technique was used to determine sensitivity to erythromycin using 15 g disks, and to chloramphenicol with 30 g disks. All procedures were performed and analyzed according to the standards set by the National Committee for Clinical Laboratory Standards (NCCLS) of the United States of America (14) . S. pneumoniae ATCC 49619 was used as the control strain.
The minimum inhibitory concentrations (MIC) of penicillin and ceftriaxone were determined in the isolates that exhibited diminished susceptibility to penicillin (diameter of oxacillin inhibition zone <20 mm). MICs of cotrimoxazole were also measured to determine the susceptibility of all isolates to that treatment (15) . In each case, the microdilution method was used with Mueller-Hinton broth containing 5% horse's blood in accordance with NCCLS specifications (16) .
Serotyping. The isolates that demonstrated penicillin-or multiple-drugresistance (defined as resistance to three or more antibiotics) 3 were serotyped by the quellung (Neufeld's) reaction using a panel of 12 antisera from the Stantens Seruminstitut in Copenhagen (17) .
Data analysis.
The prevalence of each category of S. pneumoniae resistance and the corresponding prevalence ratio (PR) were calculated. Confidence intervals (CI) of 95% for the PR were determined using Epi Info epidemiologic software (18) .
RESULTS
S. pneumoniae was isolated from 114 of the 272 patients' nasopharyngeal secretions, indicating a minimum colonization rate of 42%. Of the patients in whom colonization was detected, 76 (67%) were male and 38 (33%) female; 94 (82%) were under 3 years of age, and 57 of the latter (61%) were under 1 year old. The average age of S. pneumoniae carriers was 1.4 years. The highest prevalence of colonization was at 6 months of age.
Isolates of S. pneumoniae were obtained throughout the year of the study. However, Figure 1 shows that the majority of isolates (65%) were collected between May and September 1994.
Previous antibiotic treatment was documented in 36 (31%) of the 114 children with colonization. Thirty-two (89%) of this subgroup had received a ␤-lactam antibiotic, either amoxicillin (25) , penicillin G (4), amoxicillin and penicillin G (1), or a second-generation cephalosporin (2) . Seventy-five children had not received antibiotics. It was impossible to determine whether antibiotics had been administered to three children. Severe pneumonia was diagnosed in 79 patients with colonization (69%).
Reduced sensitivity to penicillin was detected in 19 S. pneumoniae isolates (17%) by the oxacillin screen. Oxacillin MICs indicated intermediate sensitivity in 12 isolates (11%) and resistance in 7 (6%). Only one penicillin-resistant strain was also resistant to ceftriaxone. Sensitivity to co-trimoxazole was intermediate in 21 isolates (18%), while 25 isolates (22%) were fully resistant to this agent. Intermediate sensitivity to erythromycin was encountered in two isolates (2%) and resistance was found in one (1%). Chloramphenicol resistance was seen in six isolates (5%) ( Table 1) .
Thirteen of the 19 S. pneumoniae isolates with low sensitivity to penicillin corresponded to serotype 23F, 2 to type 14, 1 to type 19F, and 3 were not typable. The most common serotype among the multiresistant isolates (those with low sensitivity to three or more antibiotics) was 23F (6 out of 7) ( Table 2) .
Reduced sensitivity to at least one antibiotic was found in 48 isolates (42%). All isolates resistant to penicillin were also resistant to co-trimoxazole. Multiresistance was present in seven isolates (6%), five of which were fully resistant to all of the antibiotics tested. All multiresistant isolates were resistant to penicillin and co-trimoxazole. The most common multiresistance pattern-to penicillin, chloramphenicol, and co-trimoxazole-was present in four isolates ( Table 2) .
Of the 19 patients carrying S. pneumoniae with diminished susceptibility to penicillin or multiple-drug resistance, 12 were boys and 7 were girls. Five were under the age of 1 year, eight were between 1 and 2 years, and six were between ages 3 and 5.
Colonization of the nasopharynx by penicillin-resistant or multiresistant S. pneumoniae was found in 5 of the 57 patients under 1 year of age, 8 of the 37 between 1 and 2, and 6 of the 20 between 3 and 5. A positive association was seen between increasing age and the presence of penicillin-or multiple-drug-resistant strains. Compared with children under 1 year of age, those in the 1-2-year age group had a prevalence of resistant isolates 2.4 times higher (95%CI: 0.9 to 7.0), while 3-5-year-olds experienced a prevalence 3.4 times higher (95%CI: 1.2 to 10.0). In the latter case, the tendency for the percentage of resistant isolates to increase with age was statistically significant (P = 0.02) ( Table 3) . Nine of the 36 patients known to have received previous antibiotic treatment were colonized by strains of penicillin-resistant S. pneumoniae. In contrast, only 9 of the 75 patients who had not received antibiotics were carriers of resistant isolates. Consequently, the risk of carrying resistant S. pneumoniae was 2.1 times greater (95%CI: 0.9 to 4.8) in children with previous antibiotic exposure (Table 3) .
In the children who were colonized by penicillin-resistant or multiresistant S. pneumoniae, the most common clinical diagnosis was severe pneumonia (17 of 19 cases). The frequency of resistant isolates was 3.8 times higher in cases of severe pneumonia (95%CI: 0.9 to 15.4) ( Table 3) .
DISCUSSION
Colonization of the upper respiratory tract by S. pneumoniae is common, especially in children, but the prevalence rates of colonization found in different studies have varied widely. In some cases the similarity between invasive disease agents and the nasopharyngeal isolates has been confirmed (10, 11) . Given the difficulties of establishing the etiology of pneumonia, these isolates could prove useful in determining patterns of antimicrobial susceptibility in a specific area, allowing the behavior of the serotypes responsible for invasive disease in the same area to be predicted (19).
The colonization rate documented in the present study is similar to rates reported in Uruguay (20) and in a community in the State of Virginia (U.S.A.) (21) . In contrast, studies conducted in other countries have found a higher prevalence of colonization in children with pneumonia, for example, 51% in the Philippines and 98% in Pakistan (11, 22) . In Papua New Guinea, colonization rates of 100% have been reported in 3-month-old infants (23) . Although no previous study has reported colonization rates in Colombian children with pneumonia, one recent investigation found S. pneumoniae in 46% of children in a day-care center in Santafé de Bogotá (24) . In that study, the proportion of pneumococcal carriers was highest among children under 2 years of age.
Isolates of S. pneumoniae resistant to penicillin and other antibiotics are becoming increasingly frequent. In Spain, Hungary, and South Africa, very high rates of penicillin resistance have been found in both colonizing and invasive isolates (9, 25) . The 17% frequency of diminished sensitivity to penicillin documented in this study is significantly higher than rates reported in Uruguay (3%) (20) , Pakistan (12%) (11) , and South Africa (12%) (26) . Serotypes 6, 14, 19 , and 23 have been associated with resistance to penicillin or multiple drugs. These serotypes represent 60% of isolates found in children under 2 years old (5, 21) . A clone of serotype 23F with resistance to penicillin and other antibiotics was first discovered in Spain; later, it was found in South Africa and the United States (27, 28) . In the present study, 68% of isolates resistant to penicillin belonged to serotype 23F. In Mexico, serotype 23F has also been found to be common among multiresistant isolates, accounting for 27% (29) . Marked differences have been recorded between the colonization rates and serotypes of S. pneumoniae isolates in healthy children compared to children with pneumonia. In Uruguay, healthy children were found to have a 15% colonization rate, while children with pneumonia had a 42% rate (20) . In another study, isolates from healthy carriers were more frequently resistant than invasive isolates (29) . The 17% rate of resistance to penicillin in nasopharyngeal isolates reported in the present study is higher than the 12% rate observed in invasive pneumococcal isolates analyzed using the Colombian National Serotyping Protocol (Protocolo Nacional de Serotipificación) for S. pneumoniae (unpublished data). However, this difference could be artifactual, since blood cultures-the technique used in the National Protocol-are much less sensitive than cultures of nasopharyngeal secretions (1, 3) . Very likely, the resistance rate in the nasopharyngeal isolates is the better indicator of the behavior of circulating S. pneumoniae.
Noteworthy among the results of this study is the high percentage (40%) of colonizing S. pneumoniae with diminished susceptibility to co-trimoxazole; a substantial proportion (22%) showed complete resistance and, frequently, simultaneous resistance to cotrimoxazole and penicillin. In the past 15 years, resistance rates of S. pneumoniae to co-trimoxazole have been found to range from 18% to 40% in various countries (20, 25, 30, 31) . This level of resistance necessitates a reconsideration of the WHO recommendation, in its ARI guidelines, that this agent be used as the treatment of choice for pneumonia.
Few isolates in this study exhibited resistance to erythromycin or chloramphenicol. Therefore, resistance to these two agents seems not to be a problem in Colombia at present. In this respect the Colombian situation resembles those of the United States and Australia, where pneumococcal resistance to macrolides is low (32, 33) , and it contrasts with those of France, where such resistance reaches 29% (34) , and Spain, where 30% resistance to chloramphenicol has been found (35) . In Colombia, erythromycin and chloramphenicol are probably the treatments of choice in childhood pneumonia.
Among the factors associated with harboring or becoming infected with resistant strains of S. pneumoniae is a history of antimicrobial use (26, 36) . In South Africa, for example, individuals who received penicillin and chloramphenicol were significantly more likely to carry strains resistant to these antibiotics (30) . In this study, prior antibiotic use was significantly associated with the presence of resistant S. pneumoniae. ␤-lactam antibiotics were found to be administered most commonly. These data agree with other reports in the literature (26, 30) .
In summary, the data from this study are consistent with findings reported in other published works and indicate important associations between age, prior use of antibiotics, and colonization by S. pneumoniae with diminished antimicrobial sensitivity. An association between nasopharyngeal carriage of resistant pneumococcal isolates and the diagnosis of severe pneumonia was also indicated, but the size of the sample was not very large and the association was not statistically significant in all cases.
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Streptococcus pneumoniae es uno de los principales agentes causales de infección respiratoria aguda (IRA) en niños y su resistencia a antibióticos se ha incrementado en todo el mundo. En este estudio se determinaron los patrones de susceptibilidad a antimicrobianos de S. pneumoniae colonizante de las vías respiratorias altas en 272 niños hospitalizados por neumonía en dos hospitales de Santafé de Bogotá. Se aisló S. pneumoniae en 114 pacientes (42%). Se observó susceptibilidad disminuida a la penicilina en 19 aislamientos (17%), con sensibilidad intermedia en 12 (11%) y franca resistencia en 7 (6%). Solo 1 de los 19 aislamientos resistentes a penicilina mostró también resistencia a la ceftriaxona. Se observó sensibilidad disminuida a la eritromicina en 3 aislamientos (3%), al cloranfenicol en 6 (5%) y al cotrimoxazol (trimetoprima + sulfametoxazol) en 46 (40%). Se encontró multirresistencia en 7 aislamientos (6%). El serotipo con sensibilidad disminuida a la penicilina que se halló con mayor frecuencia fue el 23F (68.4%). Se observó una asociación entre la edad, el uso previo de antibióticos y la colonización con S. pneumoniae con susceptibilidad disminuida a la penicilina o multirresistencia. Este estudio confirma la presencia de resistencia antimicrobiana de S. pneumoniae en Colombia y resalta la importancia del uso racional de los antibióti-cos y de la implementación de la vigilancia epidemiológica sobre este agente. El Coloquio, apoyado por la Comisión Técnica Permanente de Riesgos Profesionales de la Organización Iberoamericana de Seguridad Social y difundido por la Sociedad Ecuatoriana de Seguridad Profesional (SESO) y la Asociación Chilena de Seguridad (ACHS), está dirigido a los profesionales y encargados de la seguridad e higiene laboral, salud ocupacional y medio ambiente en la industria petrolera y química de todos los países hispanoparlantes. Entre los temas centrales figuran los de auditorías medioambientales, responsabilidad integral y ecoeficiencia, herramientas informáticas para la evaluación de riesgos, epidemiología de las enfermedades ocupacionales y programas de emergencias, todo ello en relación con la industria quí-mica y el sector petrolero.
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